Trials / Completed
CompletedNCT04168879
Sphenopalatine Ganglion Block for Nasal Surery
Efficacy of Suprazygomatic Approach of Sphenopalatine Ganglion Block for Nasal Surery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
nasal surgery carries many perioperative challenges, intraoperative bleeing and its effect on surgical field i the main intraoperative concern an postoperative agitation and its serious complications is the main postoperative challenge.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacaine 0.5% Preservative-Free Injectable Solution | 1.5 ml of Bupivacaine 0.5% Preservative-Free Injectable Solution used to block the sphenopalatine ganglion by ultrasound guided suprazygomatic approach |
| DRUG | normal saline | 1.5 ml of normal saline is delivered to the sphenopalatine ganglion by ultrasound guided suprazygomatic approach |
Timeline
- Start date
- 2021-11-10
- Primary completion
- 2023-12-10
- Completion
- 2023-12-10
- First posted
- 2019-11-19
- Last updated
- 2024-05-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04168879. Inclusion in this directory is not an endorsement.